MedPath

Optimization of Ra-223 imaging protocol using gamma cameras for therapeutic and prognostic evaluation in prostate cancer patients metastatic to bone treated with Ra-223 dichloride

Not Applicable
Conditions
castration-resistant prostate cancer
Registration Number
JPRN-UMIN000024274
Lead Sponsor
Keio University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who refused to give written informed consent to this study (2) Patients who are too claustrophobic to lie down on the bed of gamma cameras in spite of the open nature of this imaging device

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establishment of the optimal imaging protocol of Ra-223 using gamma cameras in terms of quantitative accuracy and the relationship between the quantitative values of Ra-223 and therapeutic outcome or prognosis
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath